GT Molecular, Inc., a company providing ultrasensitive PCR assays for wastewater-based epidemiology testing, pathogen detection, and cancer research is pleased to announce an agreement with Roche to provide a highly multiplexed respiratory panel for wastewater surveillance on the new Roche Digital LightCycler® System.
This digital PCR assay kit co-quantifies respiratory pathogens SARS-CoV-2, influenza A, influenza B, and RSV, as well as an internal process control all within a single reaction well. The kit Is available for sale starting today.
Wastewater-based epidemiology continues to gain traction as a complement to clinical-based epidemiology by providing aggregate samples representative of entire communities. Using the Roche Digital LightCycler®, GT Molecular developed a multiplex assay kit targeting influenza A, influenza B, RSV A/B, SARS-CoV-2, along with all necessary controls. This whitepaper describes assay and system compatibility with various workflows, wastewater inhibition, longitudinal studies for monitoring atypical seasonal behavior. Use of this kit can provide rapid, actionable infectious disease trend monitoring.
Additional offerings from GT Molecular include:
RT-qPCR and digital PCR Kits targeting respiratory viruses, norovirus, C. auris, mpox, polio, and more!
Rapid, National digital PCR and NGS Wastewater and Research Testing Services
Wastewater Sample Logistics Management
Opioid and drugs of abuse testing in wastewater for community and institutional monitoring
Highly-multiplexed Cancer RUO* Panels (EGFR, KRAS, IDH 1&2, NPM1, etc.)
For more information, please visit www.gtmolecular.com